Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Natera Inc (NQ: NTRA ) 123.98 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Aug 16, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Natera Inc < Previous 1 2 ... 5 6 7 8 9 10 11 12 Next > Court Issues Favorable Ruling for Natera in False Advertising Trial Against CareDx; Eliminates all Damages July 17, 2023 From Natera, Inc. Via Business Wire Natera to Participate in Goldman Sachs 44th Annual Global Healthcare Conference June 06, 2023 From Natera, Inc. Via Business Wire Natera Announces Data from the ProActive Study that Supports Prospera™ Kidney as an Early Indicator of Transplant Rejection June 04, 2023 From Natera, Inc. Via Business Wire Analyst Expectations for Natera's Future May 30, 2023 Via Benzinga The Latest Analyst Ratings for Natera March 03, 2023 Via Benzinga New Natera Data to be Presented at the 2023 ASCO Annual Meeting in 13 Studies Across Multiple Cancer Types May 30, 2023 From Natera, Inc. Via Business Wire 10 Health Care Stocks Whale Activity In Today's Session May 26, 2023 Via Benzinga Jury Rules in Favor of Natera, Finding all Asserted Patents Valid and Infringed by ArcherDX/Invitae; Awards $19.35 Million in Past Damages for Royalties and Lost Profits May 15, 2023 From Natera, Inc. Via Business Wire Natera's Earnings Outlook February 27, 2023 Via Benzinga Why Natera Stock Is Leading Its Industry Group With A 17% Jump Today February 16, 2023 Natera snagged a key win that could help extend its patient pool. Via Investor's Business Daily Natera Reports First Quarter 2023 Financial Results May 09, 2023 From Natera, Inc. Via Business Wire Natera Announces New Publication from I-SPY2 Trial Reinforcing Clinical Utility of Signatera™ for Breast Cancer Patients in the Neoadjuvant Setting May 08, 2023 From Natera, Inc. Via Business Wire Benzinga's Top Ratings Upgrades, Downgrades For May 5, 2023 May 05, 2023 Via Benzinga Natera Announces First Quarter 2023 Earnings Conference Call May 02, 2023 From Natera, Inc. Via Business Wire Natera Announces New Signatera™ MRD Data at 2023 AACR Annual Meeting April 14, 2023 From Natera, Inc. Via Business Wire New Publication Demonstrates Utility of Natera’s Signatera™ Test in Melanoma March 22, 2023 From Natera, Inc. Via Business Wire The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector March 15, 2023 To play a permanently relevant industry with the broadest canvas possible, consider acquiring the best biotech ETFs to buy. Via InvestorPlace Catalent Stock Showing Improved Relative Strength Rating March 10, 2023 On Friday, Catalent stock earned a positive adjustment to its Relative Strength (RS) Rating, from 63 to 74. Via Investor's Business Daily Natera Announces Commercial Payor Coverage for Signatera™ March 02, 2023 From Natera, Inc. Via Business Wire Natera Reports Fourth Quarter and Full Year 2022 Financial Results February 28, 2023 From Natera, Inc. Via Business Wire Earnings Scheduled For February 28, 2023 February 28, 2023 Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report earnings for its fourth quarter. Via Benzinga Natera to Participate in Upcoming Investor Conferences February 24, 2023 From Natera, Inc. Via Business Wire Natera Appoints Ruth E. Williams-Brinkley to its Board of Directors February 23, 2023 From Natera, Inc. Via Business Wire Natera Announces Fourth Quarter and Fiscal 2022 Earnings Conference Call February 21, 2023 From Natera, Inc. Via Business Wire Why Boston Beer Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session February 16, 2023 Gainers TravelCenters of America Inc. (NASDAQ: TA) shares jumped 70.5% to $84.32 after BP announced it will acquire the company for $86 per share in cash. Via Benzinga KBR, Twilio, Roku And Other Big Stocks Moving Higher On Thursday February 16, 2023 U.S. stocks traded lower, with the Dow Jones dropping over 250 points on Thursday. Here are some big stocks recording gains in today’s session. Via Benzinga Medicare Extends Coverage of Natera’s Signatera™ MRD Test to Breast Cancer February 16, 2023 From Natera, Inc. Via Business Wire New Paper Highlights Clinical Utility of Natera’s Renasight™ Test in the Management of Kidney Disease February 02, 2023 From Natera, Inc. Via Business Wire New Signatera™ MRD Data in Gastrointestinal Cancers to be Presented at the ASCO GI Symposium 2023 January 19, 2023 From Natera, Inc. Via Business Wire Raymond James Upgrades Natera & Myriad Genetics, While Downgrading This Stock January 18, 2023 Via Benzinga < Previous 1 2 ... 5 6 7 8 9 10 11 12 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.